These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 487014)

  • 41. Estrogen replacement therapy and menopause.
    Odom MJ; Carr BR
    Compr Ther; 1987 Dec; 13(12):58-63. PubMed ID: 3440374
    [No Abstract]   [Full Text] [Related]  

  • 42. Estrogen use and postmenopausal women: a basis for informed decisions. NIH Consensus Development.
    Gastel B; Cornoni-Huntley J; Brody JA
    J Fam Pract; 1980 Nov; 11(6):851-60. PubMed ID: 7005387
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Aortic and mitral prosthetic valve replacement in age groups 61-65 & 66-70 years.
    Prasongsukarn K; Jamieson WR; Germann E; Chan F; Lichtenstein SV
    Asian Cardiovasc Thorac Ann; 2007 Apr; 15(2):127-33. PubMed ID: 17387195
    [TBL] [Abstract][Full Text] [Related]  

  • 44. FDA insists that oestrogen products for menopause carry a warning.
    Gottlieb S
    BMJ; 2003 Jan; 326(7381):126. PubMed ID: 12531839
    [No Abstract]   [Full Text] [Related]  

  • 45. Hormone replacement therapy at the menopause. The risks and benefits.
    Kovacs GT; Chick P
    Aust Fam Physician; 1990 Jan; 19(1):73-5, 78-81, 84-5. PubMed ID: 2405831
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Factors influencing thromboembolism after mitral prosthetic implants.
    Rábago G; Fraile J; Martinell J; Artiz V; Cortina J
    Z Kardiol; 1986; 75 Suppl 2():341-4. PubMed ID: 2425504
    [No Abstract]   [Full Text] [Related]  

  • 47. [Mitral valve replacement with the Björk-Shiley monostrut prosthesis: a 4-year clinical experience].
    Alajmo F; Perna AM; Calamai G; Nigro R; Cassai M; Montesi G; Braconi L; Borgioli A; Preziuso M; Palminiello A
    G Ital Cardiol; 1990 Jan; 20(1):44-9. PubMed ID: 2328857
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The modifying effect of progestogen on the response of the post-menopausal endometrium to exogenous oestrogens.
    Campbell S; McQueen J; Minardi J; Whitehead MI
    Postgrad Med J; 1978; 54 Suppl 2():59-64. PubMed ID: 740582
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A rare cause of myocardial infarction: acute inferoposterior myocardial infarction after successful intravenous thrombolytic treatment of mechanical mitral prosthetic valve thrombosis.
    Altinbas A; Kucuktepe Z; Ozaydin M; Aslan SM; Demir M; Altinbas E
    Int J Cardiovasc Imaging; 2005 Oct; 21(5):509-12. PubMed ID: 16175440
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prosthetic valve follow-up: mechanical prosthesis.
    Sutherland HD
    Med J Aust; 1972 Aug; 2(1):Suppl:35-8. PubMed ID: 4637361
    [No Abstract]   [Full Text] [Related]  

  • 51. [Menopause: an efficacious therapeutic approach necessitates a global philosophy. Interview by Robert Henry].
    Maheux R
    Union Med Can; 1989; 118(1):6-11. PubMed ID: 2711534
    [No Abstract]   [Full Text] [Related]  

  • 52. Replacement of an immobile prosthetic mitral valve: a case report.
    Mete A; Turkay C; Kumbasar D; Gölbaşi I; Sahin N; Bayezid O
    Tex Heart Inst J; 1999; 26(3):226-8. PubMed ID: 10524748
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Menopausal oestrogen use and breast cancer.
    Beral V
    Br Med J; 1980 Dec; 281(6255):1638. PubMed ID: 7448548
    [No Abstract]   [Full Text] [Related]  

  • 54. [The late results of mitral valve prosthetic replacement in patients with acquired heart defects using biological, ball and disk prostheses].
    Gromova GV; Liudinovskova RA; Dzemeshkevich SL; Tarichko IuV
    Grud Serdechnososudistaia Khir; 1993; (3):29-32. PubMed ID: 8217312
    [No Abstract]   [Full Text] [Related]  

  • 55. Plasma heparin neutralizing activity in patients with valvular stenosis and prosthetic heart valves.
    Dana B; Ellman L; Carvalho A; Daggett WM
    J Cardiovasc Surg (Torino); 1977; 18(1):29-34. PubMed ID: 833188
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Estrogen therapy during menopause and the treatment of osteoporosis.
    Noyes MA; Demmler RW
    Prim Care; 1990 Sep; 17(3):647-66. PubMed ID: 2236341
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Late results of mitral and aortic valve replacement.
    Bonchek LI; Starr A
    Isr J Med Sci; 1975; 11(2-3):152-60. PubMed ID: 1112701
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of athrombogenic therapy, especially high dose therapy of dipyridamole, after prosthetic valve replacement.
    Taguchi K; Matsumura H; Washizu T; Harao M; Kato K; Kato E; Mochizuki T; Takamura K; Mashimo I; Mirifuji K; Nakagaki M; Suma T
    J Cardiovasc Surg (Torino); 1975; 16(1):8-15. PubMed ID: 1126989
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Acute coronary embolism without valve thrombosis in a patient with a prosthetic mitral valve--successful percutaneous coronary intervention: a case report.
    Yazici M; Kayrak M; Turan Y; Koc F; Ulgen MS
    Heart Surg Forum; 2007; 10(3):E228-30. PubMed ID: 17599897
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hormone-replacement therapy. Weighing the benefits and risks.
    Harv Health Lett; 1997 Oct; 22(12):1-3. PubMed ID: 9674386
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.